Journal
BIOMEDICINE-TAIWAN
Volume 4, Issue 2, Pages -Publisher
DIGITAL COMMONS BEPRESS
DOI: 10.7603/s40681-014-0008-z
Keywords
Genetic; Pharmacogenetics; Diabetes
Categories
Funding
- China Medical University [CMU102-N-01]
Ask authors/readers for more resources
Type 2 diabetes (T2D) is a global public health concern, its prevalence in Asia, especially Taiwan, rising every year. The risk of developing T2D and diabetes complications is not only controlled by environmental but also by genetic factors. Genetic association studies have shown polymorphisms at specific loci may help identify individuals at greatest risk and response to oral antidiabetic drugs. This review probes effect of genetic profiling on T2D and its complications, using our study population as examples. Also, pharmacogenetics and pharmacogenomics of oral anitdiabetic drug will be explored.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available